Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population - Wikidata - wikimedia - TriplyDB

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

http://www.wikidata.org/entity/Q28548045

about

Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole Therapeutic Approach to Adult Fibrotic Lung Diseases Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011 The association between gastroesophageal reflux disease and recurrent respiratory papillomatosis: A systematic review.Big data analytics to improve cardiovascular care: promise and challenges.Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors.A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.Analysis of Changes in Parathyroid Hormone and 25 (OH) Vitamin D Levels with Respect to Age, Gender and Season: A Data Mining Study.Androgen Deprivation Therapy and Future Alzheimer's Disease Risk Therapy: Risks associated with chronic PPI use - signal or noise?Proton pump inhibitors: Risks of long-term use.Proton pump inhibitors and vascular function: A prospective cross-over pilot study The Indications, Applications, and Risks of Proton Pump Inhibitors Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.Proton Pump Inhibitors and the Risk of Osseointegrated Dental Implant Failure: A Cohort Study.Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.Risk of acute myocardial infarction in patients with gastroesophageal reflux disease: A nationwide population-based study Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study.How May Proton Pump Inhibitors Impair Cardiovascular Health?Proton Pump Inhibitors Accelerate Endothelial Senescence Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results.Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction.Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist.The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet.Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease.Serum magnesium and risk of new onset heart failure in men: the Kuopio Ischemic Heart Disease Study.The influence of proton pump inhibitors and other commonly used medication on the gut microbiota.Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness.PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability.A Comparison of Alkaline Water and Mediterranean Diet vs Proton Pump Inhibition for Treatment of Laryngopharyngeal Reflux.Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.No Association of Proton Pump Inhibitor Use with Fasting or Postload Glycaemia in Patients with Cardiovascular Disease: A Cross-Sectional Retrospective Study.Can Endothelial Injury Provide the Passage to Explain the Vascular Effects of Proton Pump Inhibitors?

P2860

Q26741015-ADB2DB9C-C467-4781-9BCA-6AA947FB6B66 Q26741569-FF022EE8-88AB-4386-A353-5EF48E81552D Q27231482-843EF986-9524-4D96-B7A8-5E9D93DB0383 Q28109335-BA97DEEA-C682-4934-8B4D-EE1BAB32A5F4 Q30251514-5952BCF3-ED77-46CA-B80C-FC87E0887EE8 Q31062479-F7F082F6-7557-48E7-B079-91F007551596 Q31157434-283434F3-FCFC-4E96-853A-11C6E374E724 Q33441225-88DF2918-1CAB-4F37-B744-1CE01A870FB9 Q33801130-867EB33D-E5EE-45D0-BF18-2FC45388D521 Q34504328-632FD9E9-A124-4F83-A0A4-9DA3E3D7AE0A Q34519455-2B7F5D22-6E71-435B-83B1-210A570AD0B9 Q34549406-1FCA0F17-CAEE-45CF-8AA2-9825438399C5 Q36067712-82CB5959-D90E-456E-A805-65DA48EB62BE Q36091187-7A4F140E-99EC-4D02-B6D8-5140413DCD95 Q36117874-6D44CCE8-00A7-4CA6-8B51-5612DD91AEFD Q36170237-36B96E0E-D65A-4D0B-AF07-3C9B4C3A3F85 Q36281192-937DE098-EF9D-4D71-B9FF-1E1566E848D5 Q36314770-32D2937F-A01E-4C8A-ACB1-C0E46E4829E6 Q36784692-0762E7CE-19B4-405D-9998-A5FEF492A134 Q36836236-24D44779-0C39-420A-BF89-25E2B81CA2F5 Q36846899-ADADB747-40C2-452B-9583-6B9F2DBA532B Q36892867-ECE9B6D4-A0B9-42EC-96A7-357E7E28698B Q36993998-7C87CB3E-3537-4FC7-A6B3-2FE1233ECA7F Q37013159-F05E9232-5AF8-441B-9C01-3C3BA496F9CE Q37017659-29483A84-2560-42EB-8C9E-BA07508ADBCB Q37047798-5646BACF-D61B-4DFD-9D3A-52F0D4FEE4EB Q37171592-9FD56E3E-0257-4146-BDB7-B22BFE47CA92 Q37532133-04F5047A-F6BC-4D54-B428-B95943B0F587 Q37709906-620AA074-3369-4E89-880C-E3A1CF109A7E Q38617406-AADA314A-FBF2-46F5-811B-234402085576 Q38646393-9CE6C132-E78D-4746-B420-2DEA9D054CA0 Q38668590-95E51CB8-3888-4921-B8DE-4F3925A54602 Q38862988-CC3E0E84-6E38-4043-AD97-24A81D49C8C6 Q39001908-5DD47F2D-EF86-42A6-BD7D-B0B8E6727A60 Q39523340-C91E4866-9A8A-4930-92A8-902B9F559ABB Q39879045-06EC1B6A-B74D-47EA-A982-2F9A33ABF76F Q40053716-B2264A6D-1400-4C0A-B084-0EC6BF9886AD Q40248473-0C15BB5C-210A-43FA-A732-1E51AF6AAD62 Q41035418-A0925DD3-21C9-4F14-BA04-393D0EA52C0A Q42333495-29F02883-0075-40AC-AC65-0D9C7FF6FA7B

P2860

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

http://www.wikidata.org/entity/Q28548045

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Proton Pump Inhibitor Usage an ...... tion in the General Population

@ast

Proton Pump Inhibitor Usage an ...... tion in the General Population

@en

Proton Pump Inhibitor Usage an ...... tion in the General Population

@nl

type

label

Proton Pump Inhibitor Usage an ...... tion in the General Population

@ast

Proton Pump Inhibitor Usage an ...... tion in the General Population

@en

Proton Pump Inhibitor Usage an ...... tion in the General Population

@nl

prefLabel

Proton Pump Inhibitor Usage an ...... tion in the General Population

@ast

Proton Pump Inhibitor Usage an ...... tion in the General Population

@en

Proton Pump Inhibitor Usage an ...... tion in the General Population

@nl

P1433

Q28548045-F2BF1A04-0038-4C27-9D17-DAB1F49808D5

P1476

Q28548045-82294274-48E9-47DC-ACAE-FE51D473B804

P2093

Q28548045-20492DC8-6143-41D9-A6C9-89B00C46AECB

Q28548045-6384374F-C13D-4B44-8A31-0FF5FCFFDD7E

Q28548045-AAE84B4D-8C83-44EA-BDB8-A78D003698EF

Q28548045-B232B278-7BB2-40B0-9A90-5FAFA61A6386

Q28548045-C1E01E68-A674-4F12-A7B0-5AA4A6C89DB1

Q28548045-C860CE18-C930-43E3-8707-ED3FB9901D23

Q28548045-D32EB4E5-1853-4ADE-8AFC-3F1B22C5ACA3

Q28548045-E935F5E4-62AE-45A6-A71A-1617FB7F898E

P2860

Q28548045-066E766B-7F30-4A9D-B8A9-042CFFAB29FC

Q28548045-0DDB2473-6D90-4656-9DB6-5D7A07F61DF2

Q28548045-0FD8E22C-17A2-49A6-81C3-0BA9CBB869CA

Q28548045-17A5CDEA-18F7-42A5-8093-A6733CF9DB24

Q28548045-1C35BD08-338A-49FF-8116-F5203427544E

Q28548045-1E9A3B8D-D52F-4EC7-979B-00DAFD7B409D

Q28548045-28A6FDB4-A45D-4376-A1E5-F26CFB227A4D

Q28548045-2A7A589D-1938-4807-8378-2BF91A341216

Q28548045-2BAF9168-41BA-427B-9209-DF9B2D84BAD6

Q28548045-327FE392-07C6-4B52-A0A8-A2D383D58202

P304

Q28548045-7AFF1EC9-2DC2-4B3D-846D-5E2F61BD132A

P31

Q28548045-280B5501-BE88-4ABC-A8B0-37AAB013BD54

P3181

Q28548045-0EF7BED4-1DE2-49CB-A288-7E37A2B4E48A

P356

Q28548045-C0916538-E620-4C1F-99F4-78524A9A466A

P407

Q28548045-694A820B-8325-4B81-B691-D7638C890A11

P433

Q28548045-0D6C6ECD-D261-46C6-8BF5-C5121FAC64EE

P478

Q28548045-0334C78A-AF5E-4903-A3FA-BCC7D3742130

P50

Q28548045-14C142BA-5446-42E8-81D9-67EA205F0025

P577

Q28548045-05F56F68-5CE9-4397-BE9E-F87A1604CFA2

P5875

Q28548045-98C2FEE6-C78B-4294-A975-82243617F1A6

P698

Q28548045-940BA765-E9A4-4189-BE60-6455086FC789

P921

Q28548045-0D9DFEE7-4E26-4912-8976-C09311293129

P932

Q28548045-D2C66B5C-D0D6-42CB-8ADD-80892D904CE8

P3181

P356

JOURNAL.PONE.0124653

P1433

P1476

Proton Pump Inhibitor Usage an ...... tion in the General Population

@en

P2093

Anna Bauer-Mehren

http://www.w3.org/2001/XMLSchema#string

Jake Marcus

http://www.w3.org/2001/XMLSchema#string

Kevin T Nead

http://www.w3.org/2001/XMLSchema#string

Nicholas J Leeper

http://www.w3.org/2001/XMLSchema#string

Nigam H Shah

http://www.w3.org/2001/XMLSchema#string

Paea LePendu

http://www.w3.org/2001/XMLSchema#string

Srinivasan V Iyer

http://www.w3.org/2001/XMLSchema#string

Yohannes T Ghebremariam

http://www.w3.org/2001/XMLSchema#string

P2860

The Unreasonable Effectiveness of Data

Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs

ADMA and hyperhomocysteinemia

Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes

Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author)

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

Pharmacovigilance Using Clinical Notes

Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.

Economics in the age of big data.

STRIDE--An integrated standards-based translational research informatics platform.

P304

e0124653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2282242

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0124653

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278044213

http://www.w3.org/2001/XMLSchema#string

P698

26061035

http://www.w3.org/2001/XMLSchema#string

P921

P932

4462578

http://www.w3.org/2001/XMLSchema#string